1.69
1.69 (-1.66%)
As of Jun 14, 2022
Cytomx Therapeutics, Inc. [CTMX]
Source:
Company Overview
Cytomx Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel, conditionally activated biologics designed to be localized to the tumor microenvironment. We aim to build a commercial enterprise to maximize our impact on the treatment of cancer.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 515-3185 |
Industry | manufacturing |
CEO | Sean A. Mccarthy |
Website | www.cytomx.com |